Evidence map›Paper›PMID 31500247›Full record

ReviewCells2019

How Cells Handle DNA Breaks during Mitosis: Detection, Signaling, Repair, and Fate Choice.

Ruth Thompson, Rachel Gatenby, Samuel Sidi

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ruth ThompsonDepartment of Oncology and Metabolism, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK. R.H.Thompson@sheffield.ac.uk.ORCID 0000-0002-0828-4170
Rachel GatenbyDepartment of Oncology and Metabolism, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK. rjgatenby1@sheffield.ac.uk.
Samuel SidiDepartment of Medicine, Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10025, USA. samuel.sidi@mssm.edu.
University of Sheffield · GBThe Graduate Center, CUNY · US

Funding

Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCCR01CA178162 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIDI, SAMUEL · 2013 to 2023
$3.5M
A Non-Canonical IRAK1 Signaling Pathway Triggered by Ionizing RadiationR01GM135301 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Samuel Sidi · 2019 to 2026
$2.4M
NCI NIH HHS R01 CA178162NIGMS NIH HHS R01 GM135301
6 · The paper itself

Abstract

Mitosis is controlled by a complex series of signaling pathways but mitotic control following DNA damage remains poorly understood. Effective DNA damage sensing and repair is integral to survival but is largely thought to occur primarily in interphase and be repressed during mitosis due to the risk of telomere fusion. There is, however, increasing evidence to suggest tight control of mitotic progression in the incidence of DNA damage, whether induced in mitotic cells or having progressed from failed interphase checkpoints. Here we will discuss what is known to date about signaling pathways controlling mitotic progression and resulting cell fate in the incidence of mitotic DNA damage.

Indexed as

DNA BreaksDNA RepairCell Cycle CheckpointsDNAHumansIntracellular Signaling Peptides and ProteinsMitosisSignal TransductionDNAIntracellular Signaling Peptides and Proteinscancercell fateDNA damageDNA repairmitosis

Identifiers

PMID31500247
PMCPMC6770852
OpenAlexW2971625273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.